These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 3001165)
41. Clinical Trials in CNS--SMi's Seventh Annual Conference. 25-26 November 2008, London, UK. Sherwood D IDrugs; 2009 Feb; 12(2):84-6. PubMed ID: 19204879 [No Abstract] [Full Text] [Related]
42. Isolation and identification of an endogenous ligand for the phencyclidine receptor. DiMaggio DA; Contreras PC; Quirion R; O'Donohue TL NIDA Res Monogr; 1986; 64():24-36. PubMed ID: 3012346 [No Abstract] [Full Text] [Related]
43. The burst of mitochondrial diseases: neurons and calcium. Fendyur A; Kaiserman I; Kasinetz L; Rahamimoff R Isr Med Assoc J; 2004 Jun; 6(6):356-9. PubMed ID: 15214464 [No Abstract] [Full Text] [Related]
44. [Calcium, neuronal death and neurological disease]. Jiménez-Jiménez FJ; García-Ruiz PJ; de Bustos F Rev Neurol; 1996 Oct; 24(134):1199-209. PubMed ID: 8983715 [TBL] [Abstract][Full Text] [Related]
45. A brief assessment of frontal and subcortical functions in dementia. Rothlind JC; Brandt J J Neuropsychiatry Clin Neurosci; 1993; 5(1):73-7. PubMed ID: 8428139 [TBL] [Abstract][Full Text] [Related]
46. Neuropeptides in neurologic and psychiatric disease. Res Publ Assoc Res Nerv Ment Dis; 1986; 64():1-360. PubMed ID: 3726281 [No Abstract] [Full Text] [Related]
47. The Renin-Angiotensin System and the Neurodegenerative Diseases: A Brief Review. Almeida-Santos AF; Kangussu LM; Campagnole-Santos MJ Protein Pept Lett; 2017 Nov; 24(9):841-853. PubMed ID: 28828974 [TBL] [Abstract][Full Text] [Related]
48. [Neuropsychological description of memory impairment following cortical and subcortical brain injuries]. Jodzio K Psychiatr Pol; 1995; 29(4):491-501. PubMed ID: 7568522 [TBL] [Abstract][Full Text] [Related]
49. New insights and technologies in brain grafting. Fiandaca MS; Gash DM Clin Neurosurg; 1992; 39():482-508. PubMed ID: 1360887 [TBL] [Abstract][Full Text] [Related]
50. An overview of neuropeptides. Krieger DT Res Publ Assoc Res Nerv Ment Dis; 1986; 64():1-32. PubMed ID: 2873634 [No Abstract] [Full Text] [Related]
51. Clinical perspectives on neuropeptides. Lewis DA; Bloom FE Annu Rev Med; 1987; 38():143-8. PubMed ID: 2953298 [TBL] [Abstract][Full Text] [Related]
52. Soluble proteins in normal and diseased human brain. Smith CB; Bowen DM J Neurochem; 1976 Dec; 27(6):1521-8. PubMed ID: 1003226 [No Abstract] [Full Text] [Related]
53. Protein mis-folding emerges as a "drugable" target for discovery of novel therapies for neuropsychiatric diseases of aging. Trojanowski JQ Am J Geriatr Psychiatry; 2004; 12(2):134-5. PubMed ID: 15010342 [No Abstract] [Full Text] [Related]
54. The concept of subcortical dementia. Huber SJ; Paulson GW Am J Psychiatry; 1985 Nov; 142(11):1312-7. PubMed ID: 2932922 [TBL] [Abstract][Full Text] [Related]
56. Influence of age and age-related diseases on olfactory function. Doty RL Ann N Y Acad Sci; 1989; 561():76-86. PubMed ID: 2525363 [TBL] [Abstract][Full Text] [Related]
57. L-arginine and nitric oxide in CNS function and neurodegenerative diseases. Virarkar M; Alappat L; Bradford PG; Awad AB Crit Rev Food Sci Nutr; 2013; 53(11):1157-67. PubMed ID: 24007420 [TBL] [Abstract][Full Text] [Related]
59. An overview of neuropsychiatric disturbances in the elderly. Shraberg D J Am Geriatr Soc; 1980 Sep; 28(9):422-5. PubMed ID: 7410766 [TBL] [Abstract][Full Text] [Related]